We found that longer angiotensin II infusion resulted in higher levels of hypertrophy marker proteins, which represents a more serious degree of cardiac hypertrophy, with a parallel trend between the progressive increase in IL-22/IL-22R1 protein levels and the seriousness of cardiac hypertrophy. Here, IL22RA1 is linked to cardiac hypertrophy.